Systemic candidiasis: Clinical Trials

1 trial for Systemic candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Systemic candidiasis: new trials by email Literature Review of Systemic candidiasis trials Research Report on Systemic candidiasis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study
Anidulafungin, Fluconazole, Voriconazole - Invasive Candidiasis
Phase 3CompletedPfizer2162008-07-012011-05-30

Narrower conditions

Candidemia (1)  ·  Candidiasis, Invasive (1)  ·  Torulopsis (1)

Broader conditions

Bacterial Infections and Mycoses (1)  ·  Candidiasis (1)  ·  Fungemia (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Invasive Fungal Infections (1)  ·  Mycoses (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Anidulafungin (1)  ·  Fluconazole (1)  ·  Voriconazole (1)

Sponsors

Pfizer (1)

Countries

Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Romania (1)  ·  Russia (1)

Results publications

PMID 28459966, PMID 28597967, PMID 31280481, PMID 33891293